US 7358244
Azabicycloalkane compounds
granted A61KA61K31/46A61K31/4743
Quick answer
US patent 7358244 (Azabicycloalkane compounds) held by Theravance, Inc. expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/46, A61K31/4743, A61P, A61P1/04